Microtubulin Binding Sites as Target for Developing Anticancer Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|4|10|1077-1104

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.4, Iss.10, 2004-12, pp. : 1077-1104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Noncovalent Binding to DNA: Still a Target in Developing Anticancer Agents

By  

Current Medicinal Chemistry, Vol. 23, Iss. 36, 2016-11 ,pp. : 4108-4134

Bentham Science Publishers

Access to resources Recommend Favorite

LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action

By Limonta P.   Marelli M.M.   Moretti R.M.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 709-720

Informa Healthcare

Access to resources Recommend Favorite

Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents

By  

Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. : 621-635

Bentham Science Publishers

Access to resources Recommend Favorite

Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents

By  

Current Cancer Drug Targets, Vol. 17, Iss. 5, 2017-05 ,pp. : 404-422

Bentham Science Publishers

Access to resources Recommend Favorite

Nano-Phytosome: A Developing Platform for Herbal Anti-Cancer Agents in Cancer Therapy

By  

Current Drug Targets, Vol. 19, Iss. 2, 2018-01 ,pp. : 170-180

Bentham Science Publishers

Access to resources Recommend Favorite